Literature DB >> 31263321

Leishmanicidal effects of amphotericin B in combination with selenium loaded on niosome against Leishmania tropica.

Mahshid Mostafavi1, Saeedeh Farajzadeh2, Iraj Sharifi1, Payam Khazaeli3, Hamid Sharifi4.   

Abstract

The strategy for improving the treatment of leishmaniasis by the World Health Organization, is the development of new drugs and combination therapy. The aim of this survey was to investigate the effect of amphotericin B (AmB) in combination with selenium, in a simple or niosomal form, on Leishmania tropica (L. tropica) by in vitro advanced assays. In this study, a niosomal formulation of AmB with selenium was prepared and characterized based on size and morphology. Using MTT assay, macrophage model, flow cytometry, and qPCR, the cytotoxicity and efficiency of the niosomal formulation and simple form of combination were evaluated. No toxicity was reported for both the niosomal and simple form of the combination. The niosomal formulation significantly showed higher inhibitory effect on the promastigote and amastigote forms of L. tropica than simple combination form. Interleukin (IL)-10 significantly decreased while the level of IL-12 and metacasoase as Th-1 activator significantly increased (P < 0.001). The findings of this study indicated that niosomes are the stable carriers for this combination, easy to produce and provide promising results as an effective formulation in the inhibition of extracellular and intracellular forms of L. tropica in compared with simple combination form.

Entities:  

Keywords:  Amphotericin B; Gene expression; Leishmania tropica; Niosome; Selenium

Year:  2019        PMID: 31263321      PMCID: PMC6570717          DOI: 10.1007/s12639-018-1071-2

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  68 in total

Review 1.  Delaying antimalarial drug resistance with combination chemotherapy.

Authors:  N J White
Journal:  Parassitologia       Date:  1999-09

Review 2.  Programmed cell death in trypanosomatids and other unicellular organisms.

Authors:  Alain Debrabant; Nancy Lee; Sylvie Bertholet; Robert Duncan; Hira L Nakhasi
Journal:  Int J Parasitol       Date:  2003-03       Impact factor: 3.981

3.  Programmed cell death in the unicellular protozoan parasite Leishmania.

Authors:  N Lee; S Bertholet; A Debrabant; J Muller; R Duncan; H L Nakhasi
Journal:  Cell Death Differ       Date:  2002-01       Impact factor: 15.828

4.  Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.

Authors:  R Lira; S Sundar; A Makharia; R Kenney; A Gam; E Saraiva; D Sacks
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

5.  A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis.

Authors:  V Yardley; S L Croft
Journal:  Int J Antimicrob Agents       Date:  2000-02       Impact factor: 5.283

6.  A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis.

Authors:  C P Thakur; T P Kanyok; A K Pandey; G P Sinha; A E Zaniewski; H H Houlihan; P Olliaro
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.184

Review 7.  Antimalarial compounds: from bench to bedside.

Authors:  Piero L Olliaro; Walter R J Taylor
Journal:  J Exp Biol       Date:  2003-11       Impact factor: 3.312

8.  Treatment of cutaneous leishmaniasis with ketoconazole cream.

Authors:  A Z Momeni; M Aminjavaheri; M R Omidghaemi
Journal:  J Dermatolog Treat       Date:  2003-01       Impact factor: 3.359

Review 9.  Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials.

Authors:  Yazdan Yazdanpanah; Daouda Sissoko; Matthias Egger; Yves Mouton; Marcel Zwahlen; Geneviève Chêne
Journal:  BMJ       Date:  2004-01-23

Review 10.  Selenium and its relationship to cancer: an update.

Authors:  P D Whanger
Journal:  Br J Nutr       Date:  2004-01       Impact factor: 3.718

View more
  7 in total

Review 1.  Leishmaniasis and Trace Element Alterations: a Systematic Review.

Authors:  Ali Taghipour; Amir Abdoli; Afifeh Ramezani; Ahmad Abolghazi; Mirza Ali Mofazzal Jahromi; Salar Maani; Seyede Manizhe Heidar Nejadi; Sima Rasti; Morteza Shams; Ezatollah Ghasemi
Journal:  Biol Trace Elem Res       Date:  2021-01-06       Impact factor: 3.738

2.  Evaluation of the Efficacy of Amphotericin B and Terbinafine Microemulsions and Their Combination on Cutaneous Leishmaniasis and Comparison with the Conventional Drug Form in BALB/c Mice.

Authors:  Zeynab Baharvandi; Anayatollah Salimi; Reza Arjmand; Ali Jelowdar; Abdollah Rafiei
Journal:  AAPS PharmSciTech       Date:  2022-10-14       Impact factor: 4.026

3.  New Amides Containing Selenium as Potent Leishmanicidal Agents Targeting Trypanothione Reductase.

Authors:  Mikel Etxebeste-Mitxeltorena; Daniel Plano; Socorro Espuelas; Esther Moreno; Carlos Aydillo; Antonio Jiménez-Ruiz; Juan Carlos García Soriano; Carmen Sanmartín
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

4.  Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity.

Authors:  Shabi Parvez; Ganesh Yadagiri; Archana Karole; Om Prakash Singh; Anurag Verma; Shyam Sundar; Shyam Lal Mudavath
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

Review 5.  Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential.

Authors:  Sajad Rashidi; Celia Fernández-Rubio; Reza Mansouri; Mohammad Ali-Hassanzadeh; Esmaeel Ghani; Mohammadreza Karimazar; Raúl Manzano-Román; Paul Nguewa
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

6.  New Phosphoramidates Containing Selenium as Leishmanicidal Agents.

Authors:  Mikel Etxebeste-Mitxeltorena; Daniel Plano; Socorro Espuelas; Esther Moreno; Carlos Aydillo; Antonio Jiménez-Ruiz; Juan Carlos García Soriano; Carmen Sanmartín
Journal:  Antimicrob Agents Chemother       Date:  2021-08-02       Impact factor: 5.191

Review 7.  Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological Systems.

Authors:  Eliana B Souto; João Dias-Ferreira; Sara A Craveiro; Patrícia Severino; Elena Sanchez-Lopez; Maria L Garcia; Amélia M Silva; Selma B Souto; Sheefali Mahant
Journal:  Pathogens       Date:  2019-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.